# Alamar Biosciences, Inc.: Form 4, filed Oct 27, 2026

- Company: [Alamar Biosciences, Inc.](/companies/almr.md) (CIK 2104204)
- Form: 4
- Filed: 2026-10-27
- Accepted by EDGAR: Oct 27, 2026, 16:10 ET
- Period: 2026-10-23
- Accession: 0001231919-26-001501
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2104204/000123191926001501/xslF345X06/form4-10272026_041002.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2104204/000123191926001501/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2104204/000123191926001501/xslF345X06/form4-10272026_041002.xml

Filed Oct 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001231919-26-001501. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.